Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1580822

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has received evidence from the life sciences industry of the impact on UK R&D investment and potential increases in payment rates under the voluntary and statutory schemes for branded medicines; and if it will make a statement.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	132374
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department has been consulting on a proposed update to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory <ins class="ministerial">s</ins><del class="ministerial">S</del>cheme for branded medicines and the life sciences industry has been able to <ins class="ministerial">give evidence</ins><del class="ministerial">express its views</del> as part of this consultation process.</p><p><del class="ministerial">In considering the responses, the Department is carefully taking into account any evidence submitted on potential impacts for the United Kingdom life sciences sector.</del></p><p>The Government remains firmly committed to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory and <ins class="ministerial">v</ins><del class="ministerial">V</del>oluntary schemes for branded medicines and to working with the pharmaceutical industry to deliver on the ambitions set out in the Life Sciences Vision to create an environment that facilitates innovation for the development of medicines in the UK.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/02/2023 11:22:27 question first ministerially corrected 01/02/2023 11:38:17 answering member 4423 label Biography information for Will Quince previous answer version 51971 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4092 label Biography information for Stephen Metcalfe

1580823

registered interest
date	25/01/2023
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has made an assessment of a potential link between (a) the rebate in the Voluntary Scheme for Branded Medicines Pricing and Access and (b) the accompanying Statutory Scheme on the level of foreign direct investment into UK R&D.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	132375
answer	answer is ministerial correction date of answer 02/02/2023 answer text <p>The Government is working to better understand the impacts the operation of the current Voluntary Scheme and the accompanying Statutory Scheme on investments in the UK. We are therefore in direct conversations with companies to understand these impacts. The Department for Business, Energy and Industrial Strategy is in close discussions with the Department of Health and Social Care, the Department responsible for the Voluntary Scheme and Statutory Scheme, about the business environment for life sciences and its impact on investment.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/02/2023 16:45:03 answering member 4020 label Biography information for George Freeman
tabling member	4092 label Biography information for Stephen Metcalfe

1458180

registered interest
date	19/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research into intra-nasal covid-19 vaccines.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	906532
answer	answer is ministerial correction date of answer 19/04/2022 answer text <p>The Department of Health and Social Care commissions research through the National Institute for Health and Care Research (NIHR) which, with UK Research and Innovation, has co-funded an Imperial College London study worth £580,000 looking specifically at the safety and effectiveness of two COVID-19 vaccines administered via the respiratory tract.</p><p>The study is ongoing but in later stages and results will be made public in due course and following peer review.</p><p>The NIHR is also providing infrastructure support to an Oxford University study looking at safety and effectiveness of intranasal administration of the Oxford/AstraZeneca vaccine.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 19/04/2022 16:20:30 answering member 4447 label Biography information for Maggie Throup
tabling member	4092 label Biography information for Stephen Metcalfe